Proteinase K market expected to reach $2.5 billion by 2032 with 7.5% CAGR growth

From GlobeNewswire: 2024-12-05 07:00:00

The proteinase K market was worth around USD 1.3 billion in 2023, with an expected 7.5% CAGR growth from 2024 to 2032. Factors like chronic and infectious diseases, biotechnology advancements, and molecular diagnostics drive market expansion. Proteinase K plays a crucial role in research related to chronic diseases and infectious conditions. The U.S. dominated the North American market with USD 456.2 million in revenue in 2023, driven by academic and research institutions’ high consumption. Major players in the market include Abcam, Agilent Technologies, Merck, and Thermo Fisher Scientific.



Read more at GlobeNewswire: Proteinase K Market to hit USD 2.5 billion by 2032, says